The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,200.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 350.00 (3.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 11,200.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Term Loan and Acquisition Facility

23 Dec 2014 14:10

RNS Number : 6123A
Judges Scientific PLC
23 December 2014
 

 

 

 

Judges Scientific plc

 

23 December 2014

 

 

Judges Scientific plc

New Term Loan and Acquisition Facility

 

Judges Scientific plc ("the Group") is pleased to announce that it has agreed a new acquisition facility with its bank, Lloyds Bank plc (the "Bank").

 

All existing term loans, with the exception of the loans granted to the Company's 51% owned subsidiary, Bordeaux Acquisition Limited, have been consolidated into one £11.3 million term loan repayable in 20 quarterly instalments (the "Term Loan"). In addition, the Group has entered into a new £10.0 million revolving acquisition facility (the "Acquisition Facility"). The Acquisition Facility has been put in place to simplify the acquisition funding process both for "permitted acquisitions", which fall within set criteria, and for larger transactions where the consent process has been streamlined. The 'revolving' characteristic also serves to streamline the process in respect of any increase in the Acquisition Facility that may be agreed with the Bank in the future.

 

Taken together, the introduction of the Acquisition Facility alongside the Term Loan will enable the Group to operate its facilities in a more cost effective manner through the optimum application of cash generated from the business. In particular, it will eliminate the need to maintain large unproductive cash balances. The immediate impact on earnings per share is not expected to be material. However, the new pricing structure will ensure that the interest margin for both facilities, which will fluctuate by reference to gearing, will create opportunities for cost benefits.

 

Ralph Cohen, the Company's Finance Director, commented: "The Group has reached a size and scale which warrants a more appropriate banking structure. This will facilitate M&A transactions and is testament to Lloyds Bank's long-standing support of the Group's growth strategy".

 

 

 

For further information please contact:

Judges Scientific plc

David Cicurel, CEO

Tel: 01342 323 600

 

Shore Capital (Nominated Adviser & Broker)

Pascal Keane

Edward Mansfield

Tel: 020 7408 4090

 

Cardew Group (Financial Public Relations)

Melvyn Marckus

Tel: 0207 930 0777 or 07775 896 491

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGGCUPUPCGCW
Date   Source Headline
3rd May 20243:01 pmRNSNotice of General Meeting
1st May 20247:00 amRNSTotal Voting Rights
16th Apr 20247:00 amRNSDirector/PDMR Shareholding
9th Apr 20245:29 pmRNSDirector/PDMR Shareholding
2nd Apr 202410:41 amRNSTotal Voting Rights - Correction
2nd Apr 20249:03 amRNSTotal Voting Rights
25th Mar 20246:01 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSFinal Results
7th Mar 20247:00 amRNSDirector/PDMR Shareholding
4th Mar 202411:04 amRNSTotal Voting Rights
22nd Feb 20245:20 pmRNSHolding(s) in Company
6th Feb 20243:03 pmRNSDirector/PDMR Shareholding
5th Feb 20249:32 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSAcquisition of Luciol Instruments SA
24th Jan 20245:52 pmRNSGrant of Options
18th Jan 20247:00 amRNSFull Year Trading Statement and Notice of Results
8th Jan 20242:21 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:49 amRNSTotal Voting Rights
21st Dec 20234:16 pmRNSDirector/PDMR Shareholding
21st Dec 20239:13 amRNSBlock listing Interim Review
7th Dec 202311:18 amRNSDirector/PDMR Shareholding
1st Dec 202311:20 amRNSTotal Voting Rights
22nd Nov 202310:41 amRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSBoard Changes
15th Nov 202312:54 pmRNSDirector/PDMR Shareholding
9th Nov 202312:36 pmRNSDirector/PDMR Shareholding
9th Oct 202311:36 amRNSDirector/PDMR Shareholding
3rd Oct 202311:13 amRNSTotal Voting Rights
26th Sep 202310:37 amRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSInterim Results
6th Sep 20237:00 amRNSNotice of Investor Presentation
2nd Aug 20233:02 pmRNSTotal Voting Rights
26th Jul 202311:20 amRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNSHalf Year Trading Update and Notice of Results
10th Jul 20233:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20233:44 pmRNSTotal Voting Rights
22nd Jun 20233:09 pmRNSBlock listing Interim Review
14th Jun 20238:44 amRNSDirector/PDMR Shareholding
6th Jun 20238:45 amRNSPayment of Earn-out and Issue of Equity
5th Jun 20234:17 pmRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSBlocklisting Application and Total Voting Rights
22nd May 20231:45 pmRNSResult of AGM
12th May 20232:01 pmRNSPurchase of Ordinary Shares
9th May 202312:37 pmRNSDirector/PDMR Shareholding
3rd May 20237:00 amRNSNotice of AGM
2nd May 20231:00 pmRNSTotal Voting Rights
2nd May 20237:00 amRNSAcquisition of Bossa Nova Vision LLC
25th Apr 20235:55 pmRNSDirector/PDMR Shareholding
6th Apr 20232:50 pmRNSDirector/PDMR Shareholding
4th Apr 202312:21 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.